Radiation may tame Treatment-Resistant breast cancer

NCT ID NCT07672743

First seen Jun 29, 2026 · Last updated Jun 30, 2026 · Updated 1 time

Summary

This study tests whether high-dose radiation can control tumors in people with locally advanced or recurrent metastatic breast cancer that has not responded to systemic therapy. Participants receive radical-dose radiotherapy, and those with large tumors (5 cm or more) may get a special technique called spatially fractionated radiation therapy. The goal is to see if this approach can shrink or stabilize tumors when other treatments have failed.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Radiation therapy (radical dose radiotherapy, including spatially fractionated radiation therapy)
What this could lead to
If successful, this approach could offer a way to control locally advanced or recurrent breast cancer that has stopped responding to standard treatments.
What could go wrong
This is a small, early-phase study with only 29 participants, so results may not apply broadly. Radiation can cause side effects like skin irritation, fatigue, or damage to nearby tissues.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Cancer Hospital, Chinese Academy of Medical Sciences

    Beijing, Beijing Municipality, 100021, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.